Abstract:Infection of mice with Plasmodium berghei ANKA, a murine malaria species, induces remodeling of cerebral endothelial cells, a process which primes the endothelium for the recruitment of inflammatory cells and infected red blood cells to the cerebral microvasculature. Vascular pathology also leads to neuroinflammation, involving the activation of glial cells and abnormal expression of tau proteins in neurons, leading to cognitive dysfunction. Passive immunization to pathological tau with an anti‐PHF‐1 monoclonal antibody mitigates microglial activation and malaria‐induced endotheliopathy, ultimately resulting in the preservation of cognitive function. iR, infected red blood cell; JP, junctional protein; RBC, red blood cell; P, platelet; PHF‐1, paired helical filament 1. Cerebral malaria (CM), a potentially fatal encephalopathy caused primarily by infection with Plasmodium falciparum, results in long‐term adverse neuro‐psychiatric sequelae. Neural cell injury contributes to the neurological deficits observed in CM. Abnormal regulation of tau, an axonal protein pathologically associated with the formation of neurofibrillary lesions in neurodegenerative diseases, has been linked to inflammation and cerebral microvascular compromise and has been reported in human and experimental CM (ECM). Immunotherapy with a monoclonal antibody to pathological tau (PHF‐1 mAB) in experimental models of neurodegenerative diseases has been reported to mitigate cognitive decline. We investigated whether immunotherapy with PHF‐1 mAB prevented cerebral endotheliopathy, neural cell injury, and neuroinflammation during ECM. Using C57BL/6 mice infected with either Plasmodium berghei ANKA (PbA), which causes ECM, Plasmodium berghei NK65 (PbN), which causes severe malaria, but not ECM, or uninfected mice (Un), we demonstrated that when compared to PbN infection or uninfected mice, PbA infection resulted in significant memory impairment at 6 days post‐infection, in association with abnormal tau phosphorylation at Ser202/Thr205 (pSer202/Thr205) and Ser396–404 (pSer396–404) in mouse brains. ECM also resulted in significantly higher expression of inflammatory markers, in microvascular congestion, and glial cell activation. Treatment with PHF‐1 mAB prevented PbA‐induced cognitive impairment and was associated with significantly less vascular congestion, neuroinflammation, and neural cell activation in mice with ECM. These findings suggest that abnormal regulation of tau protein contributes to cerebral vasculopathy and is critical in the pathogenesis of neural cell injury during CM. Tau‐targeted therapies may ameliorate the neural cell damage and subsequent neurocognitive impairment that occur during disease.

Discrete class I molecules on brain endothelium differentially regulate neuropathology in experimental cerebral malaria

Ag-dependent Engagement of CD8+ T Cells with H-2Kb on Brain Endothelium Required for CD8+ T Cell entry and Cerebral Manifestation of Malaria

Conditional ablation of H-2Kb and H-2Db on discrete APC subsets modulate outcomes in experimental cerebral malaria

CD8 T cell mediated blood-brain barrier disruption promotes vascular leakage and edema in vital brain regions during experimental cerebral malaria

Systems-based identification of new adjunct therapies for treatment of malaria-induced cerebral pathology

Breakdown of the blood brain barrier in Experimental Cerebral Malaria is caused by CD8+ T cells with low affinity TCRs

Pathogenic CD8+ T cells in experimental cerebral malaria

Endothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral Malaria

Targeting the CD146/Galectin-9 axis protects the integrity of the blood–brain barrier in experimental cerebral malaria

Pathogenic mechanisms of egress unveiled by a microvascular 3D blood-brain barrier model

Cerebral Malaria and Neuronal Implications of Plasmodium Falciparum Infection: From Mechanisms to Advanced Models

Upregulation of Neuronal VEGF in Experimental Cerebral Malaria Coincides with Disease Severity Biomarkers in Humans: A Novel Mechanism of Pathophysiology

CD8 T cell mediated disruption of tight junctions is associated with vascular permeability in vital brain regions during experimental cerebral malaria (MPF7P.708)

EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria

The Ins and Outs of Cerebral Malaria Pathogenesis: Immunopathology, Extracellular Vesicles, Immunometabolism, and Trained Immunity

Comparison of CD8+ T Cell Accumulation in the Brain During Human and Murine Cerebral Malaria

Cytokines and Chemokines in Cerebral Malaria Pathogenesis

Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism

Elimination of intravascular thrombi prevents early mortality and reduces gliosis in hyper-inflammatory experimental cerebral malaria

Effects of anti‐tau immunotherapy on reactive microgliosis, cerebral endotheliopathy, and cognitive function in an experimental model of cerebral malaria

Brain Endothelium: The “Innate Immunity Response Hypothesis” in Cerebral Malaria Pathogenesis